A drug commonly used to induce labor could offer new hope in the fight against neurodegenerative diseases such as Alzheimer's and Parkinson's. Prostaglandin F2α (PGF2α), known to stimulate uterine contractions during childbirth, has been shown to be able to restore the brainwashing system in aged mice, improving the elimination of toxic waste associated with neurodegeneration.
🔬 The study and the researchers involved
The research was conducted by an international team led by Professor Douglas Kelley from the Department of Mechanical Engineering at the University of Rochester, in collaboration with the Center for Translational Neuromedicine – Division of Glial Diseases and Therapeutics. The results were published in Nature Communications
🧪 How prostaglandin F2α works in the brain
The glymphatic system, discovered in 2012, is responsible for removing waste from the brain through cerebrospinal fluid. As we age, this system loses efficiency, leading to the accumulation of toxic proteins such as beta-amyloid and alpha-synuclein, which are implicated in Alzheimer's and Parkinson's disease, respectively.
In aged mice treated with PGF2α, the glymphatic system showed significant improvement, with increased cerebrospinal fluid flow and a reduction in toxic waste.
